Title

Summary

Nitric oxide-coated balloons may prevent vessel injury

The ‘Holy Grail’ of percutaneous interventional research for many years was the prevention of in...[more]

Cellular ‘wrap’ may help regenerate damaged vessels

Pervasis Therapeutics has developed a new concept in treating acute vascular injuries in a numbe...[more]

Engineers seek to improve vascular grafts

New biomaterials have been developed by biomedical engineers at Washington University to help re...[more]

Implantable system to control hypertension

CVRx has received a conditional investigational device exemption (IDE) approval from the FDA to ...[more]

Stem cell-coated regenerative stent

Lombard Medical has announced that, in conjunction with Axordia and the University of Sheffield,...[more]

EPCs could stimulate vascular Regeneration

Endothelial progenitor cells (EPCs) or angioblasts were originally thought to be present only du...[more]

Autologous stem cells may treat coronary disease

Stem cell biology is one of the most exciting areas of medical research and researchers are alre...[more]

Reversing heart attack damage

Combining an agent that overcomes a natural inhibitor of cell division with a naturally occurrin...[more]

Tryton Medical: Bifurcation lesions treated, definitively

Tryton Medical is the leading developer of stents designed to definitively treat bifurcation les...[more]

TyRx Pharma submits ICD pouch to the FDA

TyRx Pharma has filed a Premarket Application for PIVIT CRM, an innovative mesh pouch coated wit...[more]

Remon ImPressure device utilised in first patients

Remon Medical Technologies has announced the first European use of its implantable haemodynamic ...[more]

Pro-drug to revolutionise DES concept

Researchers at the Technion-Israel Institute of Technology are proposing a revolutionary approac...[more]

CardioPass trial gains Ethics approval

CardioTech International has received the necessary approval from the Ethics Committee of the Eu...[more]

Successful implantation of vena cava filter for DVT

Ten patients have been successfully implanted with Rex Medical’s Option Retrievable Vena Cava Fi...[more]

Adult stems cells may form specific cell types

A researcher at the University of Missouri-Columbia has managed to isolate adult stem cells from...[more]

FDA to listen to CorCap data

Acorn Cardiovascular will meet with a FDA Administration panel in December to consider scientifi...[more]

Abbott/Boston launch DES

Abbott Vascular has initiated the international launch of the Xience V everolimus-eluting corona...[more]

Medtronic launches transcatheter valve replacement system

Medtronic has received the CE mark for its Melody Transcatheter Pulmonary Valve and Ensemble Tra...[more]

Cardiovascular market continues to grow

St Jude, Possis Medical and J&J have reported on their financial platforms, all securing solid t...[more]

FoxHollow and Merck expand plaque agreement

FoxHollow Technologies and Merck & Co have expanded the scope of their existing strategic collab...[more]

J&J to sue Boston Scientific/Abbott over Guidant takeover

Following Boston Scientifics' acquisition of Guidant from under the noses of its arch-rival in t...[more]

Cordis to distribute Brivant’s interventional products

Cordis Corporation has signed a definitive agreement to be the worldwide distributor of Brivant'...[more]

SurModics makes new investment in OctoPlus

SurModics has made an additional investment in OctoPlus NV, a biopharmaceutical company based in...[more]

CV Therapeutics receives notices of allowance for DES technology

CV Therapeutics has received Notices of Allowance from the US Patent and Trademark Office and fr...[more]

CardioVascular Technologies announces patent notice of allowance for its Coupler Technology

CardioVascular Technologies has recently received a Notice of Allowance for its patent applicati...[more]